Back |
home / stock / pcvx / pcvx message board
Subject | By | Source | When |
---|---|---|---|
PCVX -18% on VAX-24 delay reported last night | DewDiligence | investorshub | 03/30/2021 4:17:04 PM |
Adding | Pennybuster | investorshub | 02/19/2021 2:10:24 AM |
Vaxcyte Promotes Andrew Guggenhime to President and Chief | Phosphene | investorshub | 12/22/2020 5:38:36 PM |
SEC Form 4. Director William Newell purchased 22,228 shares | Phosphene | investorshub | 12/15/2020 4:08:01 PM |
Vaxcyte to Present at Jefferies Virtual London Healthcare Conference | Phosphene | investorshub | 11/19/2020 10:40:46 PM |
Vaxcyte is hiring. | Phosphene | investorshub | 10/13/2020 1:58:27 PM |
Low volume but solid rise today with Q | Phosphene | investorshub | 08/13/2020 10:15:51 PM |
Grant Pickering, MBA -Vaxcyte, President & Chief Executive | Trend-Setter | investorshub | 07/05/2020 3:38:21 PM |
News, Short Squeeze, Breakout and More Instantly...
SAN CARLOS, Calif., July 02, 2024 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, today announced it has appointed John Furey, a seasoned industry expert, to its Boa...
2024-06-23 20:02:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-23 06:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...